This clinical study is exploring whether an investigational study drug can help preserve the body’s ability to make insulin and reduce the need for daily insulin therapy, while keeping blood glucose levels within acceptable limits.

• Participant must be between the ages of 1 and 25

• Participant must have received diagnosis of Type One Diabetes very recently*.

(*within the past few weeks prior to submission)

Gain access to cutting-edge medications before they are widely available.